GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
BMP Sunstone Corporation (BJGP) [hlAlert]

Rating:
Outperform
BJGP
up 140.38 %

BMP Sunstone Corporation (BJGP) rated Outperform with price target $7 by Oppenheimer

Posted on: Friday,  Aug 13, 2010  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform BMP Sunstone Corporation (NASDAQ: BJGP) on 08/13/2010. Previously Oppenheimer rated Outperform BMP Sunstone Corporation (NASDAQ: BJGP) on 06/24/2009.,
when the stock price was $4.16. Since then, BMP Sunstone Corporation has gained 140.38% as of 02/24/2011's recent price of $10.00.
If you would have followed the previous Oppenheimer's recommendation on BJGP, you would have gained 140.38% of your investment in 610 days.

BMP Sunstone Corporation, formerly Beijing Med-Pharm Corporation, is a specialty pharmaceutical company with over-the-counter (OTC) manufacturing, marketing and distribution based in China. Through its subsidiary, Sunstone (Tangshan) Pharmaceutical Co., Ltd. (Sunstone) it manufactures, markets and distributes OTC products in China. Through Beijing Medpharm Co. Ltd. (BMP China), Beijing Wanwei Pharmaceutical Co., Ltd., (Wanwei), and Shanghai Rongheng Pharmaceutical Company (Rongheng), it offers to foreign and domestic pharmaceutical manufacturers in China, services focused primarily on marketing and promotional services and distribution services. It operates in three segments: branded OTC segment, which includes the operations of Sunstone, Pharmaceutical Distribution segment, which includes the operations of Wanwei and Rongheng and Licensed Products segment, which includes the operations of BMP China. On July 4, 2008, it completed the acquisition of 63.3% interest in Rongheng.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/13/2010 8:25 AM Buy
None
6.07 7.00
as of 12/31/2010
1 Week   
1 Month up  0.30 %
3 Months up  30.39 %
1 YTD up  74.16 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/16/2010 8:25 AM Buy
None
5.52 7.00
6/24/2009 8:25 AM Buy
None
4.16 6.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy